Trimetazidine

Trimetazidine is a medication used to treat angina pectoris, a condition characterized by chest pain due to reduced blood flow to the heart muscle. It is a selective fatty acid oxidation inhibitor, which means it helps the heart muscle use glucose more efficiently and reduces the need for fatty acid oxidation. This leads to improved oxygen supply to the heart muscle and reduces the severity and frequency of angina attacks. Trimetazidine is typically prescribed as a tablet to be taken three times daily, with or without food. It is important to follow the doctor’s instructions and continue taking the medication even if the symptoms improve, as discontinuation may lead to a recurrence of chest pain. Common side effects of trimetazidine include headache, dizziness, and gastrointestinal issues such as nausea, diarrhea, and constipation. However, these side effects are usually mild and do not require discontinuation of the medication. Patients should consult their healthcare provider if they experience any severe or persistent side effects.